Ventral striatum, but not cortical volume loss, is related to cognitive dysfunction in type 1 diabetic patients with and without microangiopathy

Diabetes Care

Volumn 37, Issue 9, 2014, Pages 2483-2490

  Van Duinkerken, Eelco ^a   Schoonheim, Menno M ^a   Steenwijk, Martijn D ^a   Klein, Martin ^a   Ijzerman, Richard G ^a   Moll, Annette C ^a   Heymans, Martijn W ^a   Snoek, Frank J ^a   Barkhof, Frederik ^a   Diamant, Michaela ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGE; ARTICLE; ATTENTION; BRAIN CORTEX; BRAIN SIZE; CAUDATE NUCLEUS; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS STRIATUM; CORTICAL THICKNESS (BRAIN); DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENDER; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NUCLEUS ACCUMBENS; PROLIFERATIVE RETINOPATHY; PUTAMEN; RIGHT HEMISPHERE; SYSTOLIC BLOOD PRESSURE; THALAMUS; ADOLESCENT; CASE CONTROL STUDY; COGNITION DISORDERS; COMPARATIVE STUDY; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FOLLOW UP; HYPERGLYCEMIA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS; PSYCHOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CEREBRAL CORTEX; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; PROGNOSIS; VENTRAL STRIATUM; YOUNG ADULT;

EID: 84906691538     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc14-0016     Document Type: Article

References (35)

1. Brownlee M. The pathobiology of diabetic complications: A unifying mechanism. Diabetes 2005;54:1615-1625
2. Jacobson AM, Musen G, Ryan CM, et al.; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842-1852
3. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care 2005;28:726-735
4. Jacobson AM, Ryan CM, Cleary PA, et al.; Diabetes Control and Complications Trial/EDIC Research Group. Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: An 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort. Diabetologia 2011;54:245-255
5. Wessels AM, Simsek S, Remijnse PL, et al. Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia 2006;49:2474-2480
6. vanDuinkerken E, KleinM, SchoonenboomNS, et al. Functional brain connectivity and neurocognitive functioning in patients with long-standing type 1 diabetes with and without microvascular complications: amagnetoencephalography study. Diabetes 2009;58:2335-2343
7. van Duinkerken E, Schoonheim MM, Ijzerman RG, et al. Diffusion tensor imaging in type 1 diabetes: decreased white matter integrity relates to cognitive functions. Diabetologia 2012;55:1218-1220
8. van Duinkerken E, Schoonheim MM, Sanz- Arigita EJ, et al. Resting-state brain networks in type 1 diabetic patients with and without microangiopathy and their relation to cognitive functions and disease variables. Diabetes 2012; 61:1814-1821
9. Wessels AM, Scheltens P, Barkhof F, Heine RJ. Hyperglycaemia as a determinant of cognitive decline in patients with type 1 diabetes. Eur J Pharmacol 2008;585:88-96
10. Kodl CT, Franc DT, Rao JP, et al. Diffusion tensor imaging identifies deficits in white matter microstructure in subjects with type 1 diabetes that correlate with reduced neurocognitive function. Diabetes 2008;57:3083-3089
11. Lyoo IK, Yoon S, Jacobson AM, et al. Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression. Arch Gen Psychiatry 2012;69:1267-1276
12. Franc DT, Kodl CT, Mueller BA, Muetzel RL, Lim KO, Seaquist ER. High connectivity between reduced cortical thickness and disrupted white matter tracts in long-standing type 1 diabetes. Diabetes 2011;60:315-319
13. Musen G, Lyoo IK, Sparks CR, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006;55:326-333
14. Hughes TM, Ryan CM, Aizenstein HJ, et al. Frontal gray matter atrophy in middle aged adults with type 1 diabetes is independent of cardiovascular risk factors and diabetes complications. J Diabetes Complications 2013;27:558-564
15. Wessels AM, Rombouts SA, Remijnse PL, et al. Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia 2007;50:1763-1769
16. de Jong LW, van der Hiele K, Veer IM, et al. Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: An MRI study. Brain 2008;131:3277-3285
17. de Jong LW, Wang Y, White LR, Yu B, van Buchem MA, Launer LJ. Ventral striatal volume is associated with cognitive decline in older people: A population based MR-study. Neurobiol Aging 2012;33:424.e1-e10
18. Schoonheim MM, Popescu V, Rueda Lopes FC, et al. Subcortical atrophy and cognition: sex effects in multiple sclerosis. Neurology 2012;79: 1754-1761
19. Lobnig BM, Krömeke O, Optenhostert-Porst C, Wolf OT. Hippocampal volume and cognitive performance in long-standing Type 1 diabetic patients without macrovascular complications. Diabet Med 2006;23:32-39
20. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjølie AK. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM complications study. Diabetologia 1995;38:437-444
21. The Diabetes Control and Complications Trial Research Group. Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 1996;124:379-388
22. Patenaude B, Smith SM, Kennedy DN, Jenkinson M. A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907-922
23. DerakhshanM, Caramanos Z, Giacomini PS, et al. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. Neuroimage 2010;52:1261-1267
24. Dale AM, Fischl B, Sereno MI. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999;9:179-194
25. Fischl B, Sereno MI, Dale AM. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999;9:195-207
26. Fischl B, Dale AM. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000;97:11050-11055
27. Fischl B, van der Kouwe A, Destrieux C, et al. Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14:11-22
28. Smith SM, Jenkinson M, Woolrich MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(Suppl. 1):S208-S219
29. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002;17:825-841
30. Anderson TW. An Introduction to Multivariate Statistical Analysis. New York, Wiley, 2003
31. Ho R. Handbook of Univariate and Multivariate Data Analysis and Interpretation With SPSS. Boca Raton, FL, Taylor & Francis Group, 2006
32. Tabachnick BG, Fidell LS. Using Multivariate Statistics. Needham Heights, Allyn and Bacon, 2001
33. Devisser A, Yang C, Herring A, et al. Differential impact of diabetes and hypertension in the brain: Adverse effects in grey matter. Neurobiol Dis 2011;44:161-173
34. Bennett CM, Wolford GL, Miller MB. The principled control of false positives in neuroimaging. Soc Cogn Affect Neurosci 2009;4:417-422
35. Green SB. How many subjects does it take to do a regression analysis. Multivariate Behav Res 1991;26:499-510